Evidence Synthesis
STYRENIX Sees Strong Shift in Key Metrics STYRENIX reported a quarterly Gross Margin of 29.95%, accelerating from 18.77% in the previous quarter, indicating a significant improvement in the company's cost management.
Evidence Synthesis
Last synthesized: 18 Sept 2026, 04:41
See how this stock's evidence score moved across recent sessions — unlock Pro for the live chart.
Full momentum history unlocks with Pro or Research.
Evidence Synthesis
STYRENIX Sees Strong Shift in Key Metrics STYRENIX reported a quarterly Gross Margin of 29.95%, accelerating from 18.77% in the previous quarter, indicating a significant improvement in the company's cost management.
Source observations behind the synthesis narrative.
| Metric | Value | Trend | |
|---|---|---|---|
| GROSS_MARGIN | 29.95 % | 18.77 | ▲ |
| MARGINAL_OPERATING_LEVERAGE | 18.77 % | 7.68 | ▲ |
| REVENUE_GROWTH_YOY | 7.1 % | 152.1 | ▼ |
| PRICE_CHANGE_PERCENT | 0.301 % | — | - |
| DAILY_VOLUME | 17,937 shares | 59,212 | ▼ |
| CLOSE_PRICE | 2,065.9 INR | 2,059.7 | ▲ |
| NEWS_SENTIMENT_SCORE | 1 score | — | - |
| ANALYST_STRONG_BUY_COUNT | 0 count | 1 | ▼ |
| TARGET_PRICE_PREMIUM | 40.37 % | — | - |